Tell us about your top U.S. Supreme Court or federal appeals court victory over the past year and how you and your team achieved the win.

In [Idenix Pharmaceuticals v. Gilead Sciences], we saved Gilead’s miracle drug that cured Hepatitis C in countless patients—and knocked down the biggest patent verdict of all time. This classic patent fight involved competing stories about a key scientific breakthrough. A jury initially awarded the other side $2.5 billion, with the potential for billions more. After trial, we worked with the trial team to persuade the judge that Idenix’s patent was invalid—then on appeal, persuaded the U.S. Court of Appeals for the Federal Circuit to invalidate their patent for a second reason too. Vindicating Gilead’s decision to fight the good fight, even in the face of huge risk, was immensely rewarding.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]